Kapoose Creek Bio Welcomes Renowned Drug Discovery Leader Dr. Stewart Fisher to Board of Directors
VANCOUVER, BC, July 30, 2025 – Kapoose Creek Bio is delighted to announce the appointment of Dr. Stewart Fisher to its Board of Directors. Globally recognized as a trailblazer in drug discovery and development, Dr. Fisher brings more than 25 years of transformative leadership across the pharmaceutical and biotech industries.
A distinguished authority in enzymology and medicinal chemistry, Dr. Fisher most recently served as Chief Scientific Officer at C4 Therapeutics, where he led the advancement of leading-edge oncology programs into clinical trials and played a pivotal role in securing more than $540 million in funding. His visionary leadership has also shaped major initiatives at the Broad Institute and AstraZeneca, where he led teams focused on infectious diseases and discovery sciences – driving the development of multiple first-in-class therapeutics.
“Dr. Fisher’s appointment marks a significant milestone for Kapoose Creek Bio,” said Dr. Eric Brown, CEO of Kapoose Creek Bio. “His exceptional expertise and proven ability to bring novel therapies to the clinic as well as to market will be invaluable as we continue to harness the power of nature to address unmet medical needs. We are honored to welcome such an esteemed leader to our Board.”
“I am thrilled to support an organization committed to scientific excellence and meaningful patient impact,” said Dr. Fisher. “The company’s mission to transform drug discovery from nature is not only compelling but also very timely, given the limitations of conventional small-molecule design, the urgent need for novel therapies, and the demand for fresh approaches.”
Based in Boston, Dr. Fisher is celebrated for forging high-impact collaborations that accelerate the translation of breakthrough science into real-world treatments. He holds a PhD in Organic Chemistry from Caltech and completed his postdoctoral work at Harvard Medical School.
About Kapoose Creek Bio
Kapoose Creek Bio is revolutionizing the discovery of drugs from nature with unprecedented speed and scale using AI and advanced multiomic technologies. With a world-unique biological library and a team of globally recognized scientists, we are dedicated to mapping the world’s natural chemistry, uncovering its incredible potential, and addressing some of the most urgent medical challenges of our time.
MEDIA CONTACT:
Francine Beck
FGS Longview
Francine.beck@fgslongview.com
416-725-3710
